Protein Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Proteins are essential for good health; people affected by genetic disorders cannot produce these proteins. Examples of such proteins include insulin, various blood clotting factors, growth hormones and others. Protein therapy ensures efficient administration of these proteins to patients suffering from deficiency, resulting in effective therapeutic benefits. It is a type of medical treatment that possesses therapeutic effects in many diseases such as diabetes, brain diseases and cancer. Protein therapeutics are classified functionally into five major groups-
Group I: Protein therapeutics with enzymatic or regulatory activity
Group II: Protein therapeutics with special targeting activity
Group III: Protein vaccines
Group IV: Protein diagnostics
The protein therapeutics market presents immense potential due to its untapped market potential and wide range of application areas. More than 100 modified therapeutic proteins have been approved for clinical use in the U.S. and European Union. At present there are various protein therapeutics in development based on their pharmacological activity, molecular mechanism of activity and their molecular types.

Browse Full Market Research of Protein Therapeutics Market :
http://www.transparencymarketresearch.com/protein-therapeutics-market.html

The protein therapeutics market can also be segmented based on product type, indication areas and geographies. The product segment includes monoclonal antibodies (mAbs), insulin, interferon, blood clotting factors and others. The various indication areas include diabetes, cancer, neurological disorders, genetic disorders and other indications. The major factors driving the protein therapeutics market are the increasing incidence of various chronic disorders such as cardiovascular, cancer and diabetes etc. and enhanced investments for the development of novel and efficient drugs. Moreover, rising number of medical insurance services and increased outsourcing of drug development processes are also expected to boost market growth. Increased awareness and high efficiency of these therapeutics with minimal side effects results in high acceptance levels by the end users. The major challenges of this market refer to the development of efficient methodologies to study the complex biological systems, catering to the individual variations and others including resistance to therapy and ensuring target efficiency.

Patent expirations of top selling protein therapeutics may mask the growth of the market. Some of the leading manufacturers of protein therapeutics are Roche Group, Sanofi, Eli Lilly & Company, Johnson & Johnson, Novartis, Bristol Myers Squibb Co., Pfizer, Inc., Amgen, Inc., and Merck Sereno S.A.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments
Key Takeaways:
By 2023, acellular skin substitutes are expected to generate a revenue of US$2.29 bn.
Ulcers expected to be a prominent application segment by 2023, estimated to generate revenue of US$2.15 bn.
North America to continue leading demand and revenue for tissue engineered skin substitutes, expected to generate US$1.96 bn by 2023.
Key segments of the Global Tissue Engineered Skin Substitutes Market

Global Tissue Engineered Skin Substitutes Market, by Type

Acellular
Cellular Allogeneic
Cellular Autologus
Others
Global Tissue Engineered Skin Substitutes Market, by Application

Burn
Diabetic Ulcers/Vascular ulcers
Others
Global Tissue Engineered Skin Substitutes Market, by Geography

North America
Europe
Asia Pacific
Latin America
The Middle East and Africa
Get Free Sample Research Report of Protein Therapeutics Market :

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2035

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.